Literature DB >> 12488162

Ambulatory mastectomy.

William C Dooley1.   

Abstract

BACKGROUND: Ambulatory mastectomy has been a topic of heated political debate with little analysis of clinical data.
METHODS: Based on extensive satisfaction surveys, an ideal surgical treatment experience was developed that decreased nausea, increased preoperative education, and reduced perioperative narcotic usage. Using this new algorithm, patients treated by a single surgeon were given the choice of overnight stay versus discharge to home with visiting nurse care.
RESULTS: From March 1 to October 31, 2001, 92 mastectomies or lumpectomy/axillary dissections were performed in 87 patients. One patient chose to remain in the center overnight. All others were discharged in less than 2.5 hours postoperatively. Perioperative complications fell to 20% of those of the prior year. Hospital charges fell 79.5%.
CONCLUSIONS: Despite lay reservations about ambulatory mastectomy, a detailed approach can result in markedly reduced health care costs without incurring additional morbidity or mortality.

Entities:  

Mesh:

Year:  2002        PMID: 12488162     DOI: 10.1016/s0002-9610(02)01051-6

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  10 in total

1.  Nocturnal episodic hypoxemia after ambulatory breast cancer surgery: comparison of sevoflurane and propofol-fentanyl anesthesia.

Authors:  Gotaro Shirakami; Yuriko Teratani; Kazuhiko Fukuda
Journal:  J Anesth       Date:  2006       Impact factor: 2.078

Review 2.  [Ambulatory and day surgery].

Authors:  M K Schäfer; E Wittenmeier
Journal:  Anaesthesist       Date:  2003-11       Impact factor: 1.041

Review 3.  Fast-track surgery: procedure-specific aspects and future direction.

Authors:  Daniel Ansari; Luca Gianotti; Jörg Schröder; Roland Andersson
Journal:  Langenbecks Arch Surg       Date:  2012-09-27       Impact factor: 3.445

4.  Omission of fentanyl during sevoflurane anesthesia decreases the incidences of postoperative nausea and vomiting and accelerates postanesthesia recovery in major breast cancer surgery.

Authors:  Gotaro Shirakami; Yuriko Teratani; Hajime Segawa; Shogo Matsuura; Tsutomu Shichino; Kazuhiko Fukuda
Journal:  J Anesth       Date:  2006       Impact factor: 2.078

5.  Factors Affecting the Postsurgical Length of Hospital Stay in Patients with Breast Cancer.

Authors:  Metehan Gümüş; Ömer Satıcı; Burak Veli Ülger; Abdullah Oğuz; Fatih Taşkesen; Sadullah Girgin
Journal:  J Breast Health       Date:  2015-07-01

6.  Breakthrough in breast reconstruction in the context of COVID-19: safety and efficiency of endoscopic breast reconstruction at a day surgery center.

Authors:  Jiao Zhou; Xinran Liu; Yu Feng; Juan Li; Xiangquan Qin; Yixuan Huang; Huanzuo Yang; Mengxue Qiu; Yang Liu; Hongsheng Ma; Qing Lv; Zhenggui Du
Journal:  Gland Surg       Date:  2021-08

7.  Improving postoperative pain management in subpectoral tissue expander implant reconstruction of the breast using an elastomeric pump.

Authors:  A Chaudhry; S Hallam; A Chambers; A K Sahu; S Govindarajulu; S Cawthorn
Journal:  Ann R Coll Surg Engl       Date:  2015-07       Impact factor: 1.891

8.  Introduction of a breast cancer care programme including ultra short hospital stay in 4 early adopter centres: framework for an implementation study.

Authors:  Mascha de Kok; Caroline N A Frotscher; Trudy van der Weijden; Alfons G H Kessels; Carmen D Dirksen; Cornelis J H van de Velde; Jan A Roukema; Antoine V R J Bell; Fred W van der Ent; Maarten F von Meyenfeldt
Journal:  BMC Cancer       Date:  2007-07-02       Impact factor: 4.430

9.  Adopting ambulatory breast cancer surgery as the standard of care in an asian population.

Authors:  Yvonne Ying Ru Ng; Patrick Mun Yew Chan; Juliana Jia Chuan Chen; Melanie Dee Wern Seah; Christine Teo; Ern Yu Tan
Journal:  Int J Breast Cancer       Date:  2014-08-12

10.  Same-day mastectomy and axillary lymph node dissection is safe for most patients with breast cancer.

Authors:  Anselm Tamminen; Tuomo Meretoja; Ilkka Koskivuo
Journal:  J Surg Oncol       Date:  2022-01-20       Impact factor: 2.885

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.